Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma

Mohamad A. Hussein, Mansoor Saleh, Farhad Ravandi, James Mason, Robert M. Rifkin, Ralph Ellison

Research output: Contribution to journalArticlepeer-review

108 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science